Georgia Allergy Immunology Asthma is categorized under Immunologists in Atlanta, GA and active since 2012.
Georgia Allergy Immunology Asthma was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Immunologists business, which does work in the B2C market, and is classified as a Immunologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Maziar Rezvani at the company’s single location by writing to 5445 Meridian Marks Road, Atlanta, Georgia GA 30342 or by phoning (404) 257-3338. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Georgia Allergy Immunology Asthma |
| Contact Person: | Maziar Rezvani |
| Address: | 5445 Meridian Marks Road, Atlanta, Georgia 30342 |
| Phone Number: | (404) 257-3338 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Immunologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Georgia Allergy Immunology Asthma was started in 2012 to provide professional Immunologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Maziar Rezvani for inquiries that concern Georgia Allergy Immunology Asthma by calling the company number (404) 257-3338, as your correspondence is most welcome. Additionally, the physical location of the single location of Georgia Allergy Immunology Asthma can be found at the coordinates 33.90581,-84.354627 as well as the street address 5445 Meridian Marks Road in Atlanta, Georgia 30342.
For its online presence, you may visit Georgia Allergy Immunology Asthma’s website at and engage with its social media outlets through on Twitter and on Facebook.